BioSpace News Archive

According to research released today by AmerisourceBergen, 78 percent of pharmacists across pharmacy settings look forward to playing a greater role in patient care and the majority expect to spend more time on patient-focused activities in the next five years.

NarrativeDx announced today that the US Patent Office has awarded to it a patent that covers the automated analysis of patient feedback, a cornerstone of consumerism strategies for many health systems.

For medical professionals, every second counts during an emergency. Their only line of defense is to stay cool, comfortable, and prepared.

Capital Square 1031, a leading sponsor of Delaware statutory trust investments, announced today that CS1031 Diversified Dialysis Portfolio, DST, comprised of nine medical office buildings in five states, has been fully subscribed by a total of 45 investors.

Through a new $21 Million, Four-Year Investment, Amgen Scholars Program to Reach Additional 1,500 Undergraduates

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that it will present data from three accepted abstracts related to MEI Pharma’s clinical stage drug development programs at the 2018 ASH Annual Meeting to be held December 1-4, 2018 in San Diego.

Award given at the HEALTHCARE ЯEVOLUTION Conference, Appley Health selected from among hundreds of applicants

Cambrooke’s Glytactin GMP and Actin Amino Acid metabolic formula product lines and Ketogenic liquid formulas for people with intractable epilepsy have been OU-D certified by the Union of Orthodox Jewish Congregations of America.

Non-genotoxic antibody drug conjugates (ADCs) potently depleted human stem cells in five abstracts on targeted conditioning programs and demonstrated survival benefit in patient-derived leukemia models

Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that new translational data for NiCord®, an investigational cell therapy in Phase 3 clinical development for allogeneic stem cell, or bone marrow, transplant, will be presented at the American Society of Hematology (ASH) 2018 Annual Meeting,